Paper33859757
Harnessing the tunable cavity of nanoceria for enhancing Y-27632-mediated alleviation of ocular hypertension.
Luo LJ and 2 others. Theranostics, 2021. Cited by 79 papers, by iCite.
Cite this record
ConductScience Library. Harnessing the tunable cavity of nanoceria for enhancing Y-27632-mediated alleviation of ocular hypertension. Papers, record 33859757. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33859757
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Harnessing the tunable cavity of nanoceria for enhancing Y-27632-mediated alleviation of ocular hypertension.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amides | Major topic |
| Nanoparticles | Major topic |
| Nitroimidazoles | Major topic |
| Ocular Hypertension | Major topic |
| Pyridines | Major topic |
| Animals | |
| Cell Line | |
| Delayed-Action Preparations | |
| Disease Models, Animal | |
| Drug Carriers | |
| Drug Delivery Systems | |
| Drug Liberation | |
| Eye | |
| Glaucoma | |
| Humans | |
| Ophthalmic Solutions | |
| Photoreceptor Cells | |
| Rabbits |
Source PubMed
References62
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17516712 | Rho GTPase/Rho kinase inhibition as a novel target for the treatment of glaucoma. | BioDrugs | 2007 | https://conductscience.org/library/papers/17516712 | PubMed |
| 2 | 23142993 | Anterior chamber paracentesis and pH values in patients with acute primary angle closure. | Graefes Arch Clin Exp Ophthalmol | 2013 | https://conductscience.org/library/papers/23142993 | PubMed |
| 3 | 24872673 | An emerging treatment option for glaucoma: Rho kinase inhibitors. | Clin Ophthalmol | 2014 | https://conductscience.org/library/papers/24872673 | PubMed |
| 4 | 17222903 | Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons. | Biomaterials | 2007 | https://conductscience.org/library/papers/17222903 | PubMed |
| 5 | 27544758 | Glaucoma: the retina and beyond. | Acta Neuropathol | 2016 | https://conductscience.org/library/papers/27544758 | PubMed |
| 6 | 20467456 | Inflammatory molecules in aqueous humour and on ocular surface and glaucoma surgery outcome. | Mediators Inflamm | 2010 | https://conductscience.org/library/papers/20467456 | PubMed |
| 7 | 21396448 | Nanoceria extend photoreceptor cell lifespan in tubby mice by modulation of apoptosis/survival signaling pathways. | Neurobiol Dis | 2011 | https://conductscience.org/library/papers/21396448 | PubMed |
| 8 | 10416754 | Neuroprotection in relation to retinal ischemia and relevance to glaucoma. | Surv Ophthalmol | 1999 | https://conductscience.org/library/papers/10416754 | PubMed |
| 9 | 11018042 | Specific activation of LIM kinase 2 via phosphorylation of threonine 505 by ROCK, a Rho-dependent protein kinase. | J Biol Chem | 2001 | https://conductscience.org/library/papers/11018042 | PubMed |
| 10 | 10640587 | Acyclovir-containing liposomes for potential ocular delivery. Corneal penetration and absorption. | J Control Release | 2000 | https://conductscience.org/library/papers/10640587 | PubMed |
| 11 | 15919228 | Changes in aqueous humor dynamics with age and glaucoma. | Prog Retin Eye Res | 2005 | https://conductscience.org/library/papers/15919228 | PubMed |
| 12 | 18758924 | Recent perspectives in ocular drug delivery. | Pharm Res | 2009 | https://conductscience.org/library/papers/18758924 | PubMed |
| 13 | 22562850 | Advances in glaucoma treatment and management: outflow drugs. | Invest Ophthalmol Vis Sci | 2012 | https://conductscience.org/library/papers/22562850 | PubMed |
| 14 | 21442374 | Increased liver uptake and reduced hepatic stellate cell activation with a cell-specific conjugate of the Rho-kinase inhibitor Y27632. | Pharm Res | 2011 | https://conductscience.org/library/papers/21442374 | PubMed |
| 15 | 24294000 | Cerium oxide nanoparticles protect rodent lungs from hypobaric hypoxia-induced oxidative stress and inflammation. | Int J Nanomedicine | 2013 | https://conductscience.org/library/papers/24294000 | PubMed |
| 16 | 28738764 | Neuroprotection by (endo)Cannabinoids in Glaucoma and Retinal Neurodegenerative Diseases. | Curr Neuropharmacol | 2018 | https://conductscience.org/library/papers/28738764 | PubMed |
| 17 | 27575454 | Recent advances in porous nanoparticles for drug delivery in antitumoral applications: inorganic nanoparticles and nanoscale metal-organic frameworks. | Expert Opin Drug Deliv | 2017 | https://conductscience.org/library/papers/27575454 | PubMed |
| 18 | 22815626 | A selective inhibitor of the Rho kinase pathway, Y-27632, and its influence on wound healing in the corneal stroma. | Mol Vis | 2012 | https://conductscience.org/library/papers/22815626 | PubMed |
| 19 | 17207782 | Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy. | Cardiovasc Res | 2007 | https://conductscience.org/library/papers/17207782 | PubMed |
| 20 | 26881021 | The Role of the Reactive Oxygen Species and Oxidative Stress in the Pathomechanism of the Age-Related Ocular Diseases and Other Pathologies of the Anterior and Posterior Eye Segments in Adults. | Oxid Med Cell Longev | 2016 | https://conductscience.org/library/papers/26881021 | PubMed |
Cited by41
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 79 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42898393 | Application of nanozyme-based drug delivery systems in the treatment of ROS-related ophthalmic diseases. | Int J Pharm X | 2026 | https://conductscience.org/library/papers/42898393 | PubMed |
| 42835137 | Mannan-oligosaccharides-based self-assembly nanoparticles enable gut-specific quercetin release, providing multi-pathway protection against AD via gut-brain axis. | J Pharm Anal | 2026 | https://conductscience.org/library/papers/42835137 | PubMed |
| 42518473 | Light-Triggered and Sustained Delivery of Dexamethasone Using Chitosan-Coated PLGA Nanoparticles for Posterior Eye Disease Treatment. | ACS Omega | 2026 | https://conductscience.org/library/papers/42518473 | PubMed |
| 42388372 | Shattering the "golden armor": A natural supramolecular nanoplatform for optical virulence modulation and MRSA keratitis therapy. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42388372 | PubMed |
| 42063460 | ROS-responsive drug delivery systems for chronic wound healing: advances, challenges, and translational perspectives. | Mil Med Res | 2026 | https://conductscience.org/library/papers/42063460 | PubMed |
| 41840931 | Development of a Cerium-Doped Titanate/Polyphenol Nanostructured Coating for Titanium Implants: Enhancing Antibacterial Properties through Ciprofloxacin Release. | ACS Appl Mater Interfaces | 2026 | https://conductscience.org/library/papers/41840931 | PubMed |
| 41725008 | Chitosan-rapamycin carbon dots rejuvenate autologous Sca-1⁺ stem cells paracrine function for neuroprotection in normal tension glaucoma. | Stem Cell Res Ther | 2026 | https://conductscience.org/library/papers/41725008 | PubMed |
| 41692731 | Mucoadhesive and corneal permeable nano eye drops for improved anti-glaucoma therapy. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/41692731 | PubMed |
| 41578928 | Dual-functional nanoparticle formulations for simultaneous intraocular pressure reduction and neuroprotection in glaucoma: a review. | Nanomedicine (Lond) | 2026 | https://conductscience.org/library/papers/41578928 | PubMed |
| 41563533 | Adverse effects of antiglaucoma medications: pathophysiology and novel drug delivery strategies for mitigation. | Int Ophthalmol | 2026 | https://conductscience.org/library/papers/41563533 | PubMed |
| 41535853 | Single-atom Pt doped nanoceria for enhanced cell phagocytosis and nanozyme activities in keratitis immune regulation. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/41535853 | PubMed |
| 41470223 | Cell Motility Dynamics in Glaucoma: Mechanisms, Pathogenic Roles, and Therapeutic Targeting. | Medicina (Kaunas) | 2025 | https://conductscience.org/library/papers/41470223 | PubMed |
| 41234295 | Next-generation smart ophthalmic biomaterials: From passive response to active interaction and closed-loop control. | Bioact Mater | 2026 | https://conductscience.org/library/papers/41234295 | PubMed |
| 40868931 | A Comprehensive Review of the Role of Rho-Kinase Inhibitors in Corneal Diseases. | Life (Basel) | 2025 | https://conductscience.org/library/papers/40868931 | PubMed |
| 40856634 | Evaluating the potential of travoprost-thymoquinone co-loaded liposomes: a glaucomatous rabbit model study. | Ther Deliv | 2025 | https://conductscience.org/library/papers/40856634 | PubMed |
| 40001147 | Frontier applications of retinal nanomedicine: progress, challenges and perspectives. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/40001147 | PubMed |
| 39897787 | Drug delivery strategies to improve the treatment of corneal disorders. | Heliyon | 2025 | https://conductscience.org/library/papers/39897787 | PubMed |
| 39818739 | Advancements and Prospects in Nanorobotic Applications for Ophthalmic Therapy. | ACS Biomater Sci Eng | 2025 | https://conductscience.org/library/papers/39818739 | PubMed |
| 39768626 | Meta-Analysis of MINIject vs. Two iStents as Standalone Treatment for Glaucoma with 24 Months of Follow-Up. | J Clin Med | 2024 | https://conductscience.org/library/papers/39768626 | PubMed |
| 39596335 | Müller Glia Co-Regulate Barrier Permeability with Endothelial Cells in an Vitro Model of Hyperglycemia. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39596335 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ATP1A1 | 476 | PubTator's text mining | https://conductscience.org/library/genes/476 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33859757
GET https://conductscience.org/api/papers/v1/33859757/references?page=2